Clinical trials
Humans clinical trials
Below are recruiting humans clinical trials, each written for real people, not researchers. We’re tracking 1,228 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07272785Recruiting
Maternal information on labor induction and birth experience
This trial studies how giving mothers more information about labor induction (starting labor with medicine) affects their birth experience. You may be able to join if you are planning an induction at a clinic or ward and speak Finnish, Swedish, or English.
TurkuAges 18 years+ - NCT07275489Recruiting
Long-term isolation and your immune system
This study looks at how long-term isolation on remote islands affects your immune system. If you are a healthy adult who will spend a year living on the Kerguelen Islands, this trial will track your health over time.
Port-aux-Français, Terres Australes Et Antarctiques FrançaisesAges 18 years+ - NCT07269665RecruitingEarly Phase 1
Gene therapy trial for children with BBS1 retinal degeneration
This early-phase trial tests a gene therapy called AXV-101 for children with vision loss caused by BBS1 genetic mutations. The goal is to see if it can help slow or stop retinal damage.
LondonAges 4–17 - NCT03899428RecruitingPhase 2
Immune therapy versus targeted therapy for advanced liver cancer
This trial compares an immune “checkpoint” medicine to a targeted cancer medicine in people with advanced liver cancer who have hepatitis B in the blood. It aims to lower hepatitis B surface antigen (HBsAg) levels and see which approach works better and is safest.
Hong Kong, Hong Kong SARAges 18 years+ - NCT03792919RecruitingPhase 4
Stopping long-term hepatitis B medicine vs continuing
This study compares outcomes for people with chronic hepatitis B who have long-term, stable viral suppression: stopping their antiviral medicine versus continuing it. It may help answer whether it’s safe to stop treatment in the right patients.
Hong Kong, Hong Kong SARAges Any age - NCT03612726Recruiting
Study for people with unresectable liver cancer
This trial looks at overall survival (how long people live) in real-world patients with unresectable liver cancer. It may help researchers understand outcomes outside of tightly controlled studies.
BeijingAges 18 years+ - NCT06528418Recruiting
Breath test to find lung diseases
This study uses a simple breath test to detect different lung diseases. By analyzing the chemicals in your breath, researchers hope to find a faster, non-invasive way to diagnose lung conditions. It may be an option if you have a known lung disease and have a recent CT scan.
Guangzhou, GuangdongAges 18–100 - NCT06896331Recruiting
Study of brain cell activity in tumor surgery patients
This trial studies electrical signals from brain cells in people having surgery to remove a brain or cerebellum tumor. It aims to better understand how these cells work.
Pavia, PaviaAges 18 years+ - NCT07266831RecruitingPhase 2/Phase 3
New HIV treatment for people not yet on medication
This study tests a new combination medicine for people with HIV who have never taken treatment. It aims to see if it is safe and helps reduce the amount of virus in the blood.
Los Angeles, CaliforniaAges 18 years+ - NCT07265622RecruitingPhase 1/Phase 2
Study of 7MW4911 for advanced solid tumors
This trial tests a new drug called 7MW4911 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective, and may be an option if you have a tumor that expresses a certain protein (CDH17).
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07262164RecruitingPhase 1
Testing VG2062 for advanced solid tumors
This trial is testing a new drug called VG2062 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how the body processes it.
HebeiAges 18–75 - NCT05442463Recruiting
Hormone effects on blood vessel narrowing in kidneys and arteries
This study looks at how hormone treatments (estrogen, progesterone, or testosterone) may affect how blood vessels tighten in the body, including in the kidneys. Researchers measure these effects to understand potential impacts on blood flow and blood vessel control.
Calgary, AlbertaAges 18–90 - NCT06025630RecruitingPhase 1/Phase 2
Testing TUDCA for blood pressure control
This study tests whether a supplement called TUDCA can help lower blood pressure by reducing stress inside cells. It's looking for people with high-normal blood pressure who are not on many heart medications.
Fort Worth, TexasAges 18–80 - NCT03844360RecruitingPhase 4
Personalized dosing of cancer or infection medicines in children
This trial looks at how to adjust the dose of cancer medicines and/or anti-infection medicines in children who have blood-related cancers. The goal is to make dosing fit each child’s needs while they receive standard treatment.
Xuzhou, JiangsuAges 1 day–18 years - NCT07255807Recruiting
Understanding insulin resistance in healthy adults
This study will look at how insulin resistance works in the body by studying healthy adults. You may help researchers find new ways to understand and treat conditions like diabetes.
CopenhagenAges 25–55 - NCT07249775Recruiting
Study of new drug FID-022 for pancreatic cancer
This trial tests a new study drug called FID-022 for people with pancreatic cancer. It is a first-in-human study, meaning it is the first time this drug is being tested in people, and researchers want to see if it is safe and how it works.
Tampa, FloridaAges 18 years+ - NCT07259070RecruitingPhase 1/Phase 2
CAR T-cells targeting BAFF-R for resistant B-cell lymphoma
This trial tests a new kind of immunotherapy called CAR T-cells that are designed to find and attack a protein called BAFF-R on your lymphoma cells. It is for people with certain types of B-cell lymphoma that have not responded well to at least two earlier treatments.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT05477849RecruitingPhase 1
Study drug for people with advanced solid tumors
This Phase 1 trial tests the safety and early effects of VG2025 in people with advanced solid cancers that have stopped responding to standard treatments. It’s mainly looking for side effects and how the body processes the drug, and it may offer a new option when other treatments haven’t worked.
Hangzhou, ZhejiangAges 18–75 - NCT07240675RecruitingPhase 1
First-in-human safety study of KLA478 in healthy volunteers
This study tests a new drug called KLA478 for the first time in humans. It is looking for healthy volunteers to see how the drug affects the body and how safe it is.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT07246590RecruitingPhase 3
Cantharidin treatment for common warts in children and adults
This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.
Saint Augustine, FloridaAges 2 years+ - NCT07248904Recruiting
HPV education study for first-year nursing students
This study tests whether a special education program based on the transtheoretical model improves nursing students' knowledge about HPV, their health beliefs, and their intentions to get vaccinated. It aims to help students make informed decisions about HPV prevention.
Adana, CUKUROVAAges 18 years+ - NCT06573749Recruiting
Milk fat globule membrane supplement for muscle function
This trial tests whether a supplement made from milk fat globule membrane can improve muscle function in healthy adults who are recreationally active. You'll take the supplement daily for 12 weeks and have your muscle function measured.
Loughborough, LeicestershireAges 18–75 - NCT02820233Recruiting
Study of a heart-signal drug during bypass surgery
This study looks at a treatment that affects signals between heart cells in people with severe coronary artery disease who are scheduled for bypass surgery. The goal is to see if changing these heart-cell signals can improve heart outcomes around the time of surgery.
Portland, MaineAges 18 years+ - NCT07235332Enrolling by invitation
How diet affects heavy metals in the body
This study compares heavy metal levels in people who eat different types of diets—vegetarian/vegan, low-carb, or traditional omnivorous. It will help understand if certain diets lead to higher or lower exposure to toxic metals.
ArielAges 20–49
Hear when a new Humans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for humans?
- Yes. Clin2 currently lists 1,228 recruiting humans studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a humans trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a humans trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.